Shilpa Medicare Limited News and Resources

mAbTree Biologics AG has entered an exclusive co-development and commercialization partnership with Shilpa Biologicals Pvt Ltd, a subsidiary of Shilpa Medicare Limited, for its novel checkpoint inhibitor. The collaboration aims to advance immunotherapy with a next-generation biologic designed to enhance T cell